Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | AMG 794 |
| Trade Name | |
| Synonyms | AMG-794|AMG794 |
| Drug Descriptions |
AMG 794 is a bispecific T-cell engager that targets CLDN6 and CD3, potentially leading to enhanced antitumor immune response and killing of tumor cells expressing CLDN6 (Cancer Res (2022) 82 (12_Supplement): 5202). |
| DrugClasses | CD3 Antibody 119 CLDN6 Antibody 10 |
| CAS Registry Number | NA |
| NCIT ID | C187347 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| AMG 794 | AMG 794 | 0 | 1 |